Last updated on February 2020

Rifaximin in Patients With Diabetic Gastroparesis


Brief description of study

Researchers are trying to determine if subjects with diabetic gastroparesis and symptoms of bloating will have a greater improvement in bloating symptoms when treated with rifaximin.

Clinical Study Identifier: NCT04254549

Find a site near you

Start Over

Mayo Clinic in Florida

Jacksonville, FL United States
  Connect »